Richard C. Birkmeyer, Ph.D.

President and CEOBoard of Directors, Core Team

Rick is a seasoned executive and an accomplished entrepreneur with a proven track record. Rick joined CD Diagnostics, Inc. in 2012 as Chief Executive Officer. CD Diagnostics is a fully integrated diagnostics company with expertise in immunoassay development and commercialization. The detection of synovial fluid biomarkers using immunoassay technology is a powerful new concept that has earned numerous awards. The company was purchased by Zimmer Biomet in 2017. Prior to CD Diagnostics, Rick founded Strategic Diagnostics, Inc. a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and life science applications.  As its CEO, Rick grew revenues to $26 million and operated the business profitably. Rick completed six acquisitions including utilizing a financial reverse merger in 1996 to create a publicly-traded company NASDAQ: (SDIX).